BridgeBio (BBIO) Reports Wider Q4 Loss of $1/Share vs $0.63 Estimate; Stock Surges 13%
BridgeBio posts wider-than-expected Q4 loss of $0.94/share on $154.2M revenue; stock surges 13% despite 50.6% earnings miss.
Breaking market news, earnings coverage, and in-depth interviews with industry leaders.
BridgeBio posts wider-than-expected Q4 loss of $0.94/share on $154.2M revenue; stock surges 13% despite 50.6% earnings miss.
Rapport Therapeutics Inc (RAPP) posted a Q4 2025 gaap loss of $0.72 per share, wider than the -$0.67...
ADC Therapeutics SA (ADCT) posted a Q4 2025 adjusted loss of $0.29 per share, wider than the -$0.27...
Priority Technology Holdings, Inc (PRTH) delivered Q4 2025 adjusted earnings of $0.27 per share, below analysts' $0.28 forecast...
Custom Truck One Source Inc (NYSE:CTOS) reported fourth quarter results that exceeded Wall Street expectations. Q4 2025 gaap...
**Arq Inc Reports Q4 2025 Earnings**
**Greenlight Capital Re Ltd Reports Q4 2025 Results**
**Voyager Technologies Inc Reports Q4 2025 Earnings**
FreightCar America Inc (RAIL) delivered Q4 2025 adjusted earnings of -$0.17 per share, below analysts' $0.19 forecast (miss...
MIND CTI Ltd (MNDO) reported Q4 2025 gaap earnings of $0.05 per share. No consensus estimate was available...
**Tenax Therapeutics Narrows Q4 Loss, Beats Expectations**